Exponent Reports Third Quarter 2026 Financial Results
Exponent reported Q3 2026 total revenues of $173.7 million, up 18% year-over-year, with revenues before reimbursements up 12% to $153.1 million. Net income rose to $30.9 million, or $0.64 per diluted share, from $0.55 a year ago, while EBITDA margin expanded to 29.4% of revenues before reimbursements on 77% utilization. Management raised full-year guidance, now expecting revenues before reimbursements to grow 10-11% with EBITDA at 28.0-28.3% of revenues before reimbursements.
Key figures
- Eps
- 0.64
- Revenue
- 173733000
- Guidance
- Q4 revenues before reimbursements to grow 8-10% YoY with EBITDA at 26.3-26.8% of revenues before reimbursements; FY26 revenues before reimbursements to grow 10-11% with EBITDA at 28.0-28.3% (raised)
- Revenue Yoy
- 18%
- Ebitda q3
- 44976000
- Ebitda ytd
- 130840000
- Revenue ytd
- 511648000
- Utilization
- 77%
- Buybacks ytd
- 146100000
- Net income q3
- 30943000
- Net income ytd
- 89907000
- Eps diluted ytd
- 1.83
- Ebitda margin q3
- 29.4%
- Dividends paid ytd
- 46100000
- Cash and equivalents
- 114689000
- Ebitda margin prior year q3
- 28.3%
- Revenues before reimbursements q3
- 153063000
- Revenues before reimbursements yoy q3
- 12%
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.